Orion Corp.
Country not established FDA
- Devices
- 21
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA establishment
What Orion Corp. makes
Orion Corp. manufactures diagnostic assays and microbiological culture devices, including immunochemical tests for apolipoproteins (A1 and B), chlamydia antibodies, and microalbuminuria. Their portfolio also includes culture media like the Oricult-N and Dentocult products for detecting bacterial strains, as well as a dental plaque analysis device (Mamex DC). They produce both single-use and revised versions of certain assays, such as the Rubalex test.
The company’s devices are regulated under FDA’s 510(k) pathway, with products classified as Class I and Class II. Their offerings are listed in the FDA’s 510(k) database, reflecting their compliance with U.S. medical device regulations. Orion Corp. operates from the United States.
Catalogue
Search and filter all 21 devicesFDA establishments
- Orion SRL IT
- Orion Corporation FI
Frequently asked questions
How many devices does Orion Corp. have in the registry?
The registry currently lists 21 devices for Orion Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Orion Corp.'s devices?
Among its 21 most recently registered devices, Orion Corp. has devices listed in FDA 510(k) (21 devices).
What risk classes do Orion Corp.'s devices fall under?
Among its 21 most recently registered devices, the classes recorded for Orion Corp.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Orion Corp. in the registry?
The most recently registered devices listed for Orion Corp. include RUBALEX, MICROALBUMINURIA ASSAY, ORICULT-N CULTURE-PADDLE and IMMUNOCHEMICAL ASSAY APOLIPOPROTEIN B.
Which FDA establishments are linked to Orion Corp.?
2 FDA establishments are linked to Orion Corp. in the registry; they are listed on the company page.